Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.2 (Beat by $0.42) |
EPS GAAP Actual | $0.2 (Beat by $0.42) |
Revenue Actual | $0.504271B |
Revenue Surprise | Beat by $504.271M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | -0.51988 | -15.73 | -2.76581 | 1.5 | 15 |
Dec 2024 | -1.06778 | -7.66 | -4.28 | 0.96 | 21 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.22 | 0.22 | 0.504271B | 9.14% | 504.27M |
FQ4 2024 (Dec 2024) | -12.51 | -12.51 | 0.518492B | 0.37% | 518.49M |
FQ3 2024 (Sep 2024) | -1.84 | -1.84 | 0.537173B | -4.84% | 537.17M |
FQ2 2024 (Jun 2024) | 0.63 | 0.63 | 0.523866B | -12.66% | 523.87M |
FQ1 2024 (Mar 2024) | -0.4 | -0.4 | 0.458188B | -28.74% | 458.19M |
FQ4 2023 (Dec 2023) | -1.6 | -1.6 | 0.51659B | -17.92% | 516.59M |
FQ3 2023 (Sep 2023) | -4.92 | -4.92 | 0.563181B | -12.2% | 563.18M |
FQ2 2023 (Jun 2023) | 0.26 | 0.26 | 0.590193B | 0.95% | 590.19M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | -0.14 | -- | -0.15897 | -0.10899 | 2 |
FQ3 2029 (Sep 2029) | -0.13 | -- | -0.14762 | -0.1012 | 2 |
FQ2 2029 (Jun 2029) | -0.12 | -- | -0.13626 | -0.09341882 | 2 |
FQ1 2029 (Mar 2029) | -0.14 | -- | -0.15897 | -0.10899 | 3 |
FQ4 2028 (Oct 2028) | -0.15 | -- | -0.18178 | -0.11549 | 15 |
FQ3 2028 (Jul 2028) | -0.15 | -- | -0.18178 | -0.11549 | 8 |
FQ2 2028 (Jun 2028) | -0.15 | -- | -0.18474 | -0.11172 | 8 |
FQ1 2028 (Mar 2028) | -0.18 | -- | -0.22169 | -0.13406 | 10 |
FQ4 2027 (Oct 2027) | -0.15 | -- | -0.18178 | -0.11549 | 10 |
FQ3 2027 (Sep 2027) | -0.16 | -- | -0.19706 | -0.11916 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 1B | -- | 0.83B | 1.1B | 5 |
FQ3 2029 (Sep 2029) | 1.02B | -- | 0.85B | 1.13B | 5 |
FQ2 2029 (Jun 2029) | 0.95B | -- | 0.79B | 1.05B | 8 |
FQ1 2029 (Mar 2029) | 0.87B | -- | 0.72B | 0.96B | 5 |
FQ4 2028 (Oct 2028) | 1.02B | -- | 0.84B | 1.18B | 7 |
FQ3 2028 (Jul 2028) | 0.92B | -- | 0.76B | 1.07B | 7 |
FQ2 2028 (Jun 2028) | 0.97B | -- | 0.78B | 1.14B | 6 |
FQ1 2028 (Mar 2028) | 0.85B | -- | 0.68B | 1B | 6 |
FQ4 2027 (Oct 2027) | 0.92B | -- | 0.75B | 1.06B | 8 |
FQ3 2027 (Sep 2027) | 0.9B | -- | 0.72B | 1.06B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.22 | 0.22 | 100% | |
FQ4 2024 (Dec 2024) | -12.51 | -12.51 | 100% | |
FQ3 2024 (Sep 2024) | -1.84 | -1.84 | 100% | |
FQ2 2024 (Jun 2024) | 0.63 | 0.63 | 100% | |
FQ1 2024 (Mar 2024) | -0.4 | -0.4 | 100% | |
FQ4 2023 (Dec 2023) | -1.6 | -1.6 | 100% | |
FQ3 2023 (Sep 2023) | -4.92 | -4.92 | 100% | |
FQ2 2023 (Jun 2023) | 0.26 | 0.26 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.5B | $504.27M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.52B | $518.49M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.54B | $537.17M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.52B | $523.87M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.46B | $458.19M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.52B | $516.59M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.56B | $563.18M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.59B | $590.19M | 100% |